title: A neonatal hepatitis B surveillance and vaccination program: New York City, 1987 to 1988.
abstract: From July 1987 to June 1988, 1030 pregnant women with hepatitis B were reported to a New York City surveillance program. Among 832 infants under follow-up, the coverage rates for combined hepatitis B immune globulin and vaccine doses 1, 2, and 3 were 84%, 77%, and 59%, respectively. Infants covered by Medicaid and uninsured Black and Hispanic infants were significantly less likely to be completely vaccinated. An estimated 160 cases of chronic hepatitis B infection were prevented among infants enrolled in the program. Strategies are needed to improve vaccine coverage among hard-to-reach groups.
authors.affiliation: New York City Department of Health, Bureau of Immunization, Epidemiology and Prevention Services, NY 10013.
authors.forename: K J
authors.initials: KJ
authors.lastname: Henning
authors.forename: D M
authors.initials: DM
authors.lastname: Pollack
authors.forename: S M
authors.initials: SM
authors.lastname: Friedman
mesh_terms: D002353:Carrier State / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D005006:Ethnicity / Q000706:statistics & numerical data; D006302:Health Services Research; D006509:Hepatitis B / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use; D007231:Infant, Newborn; D007348:Insurance, Health / Q000706:statistics & numerical data; D015997:Neonatal Screening / Q000458:organization & administration* / Q000592:standards; D009519:New York City / Q000453:epidemiology; D011159:Population Surveillance; D015397:Program Evaluation; D012042:Registries; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D012959:Socioeconomic Factors; D015819:Substance Abuse, Intravenous / Q000453:epidemiology; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D006514:Hepatitis B Surface Antigens; D016756:Immunoglobulins, Intravenous; D014761:Viral Hepatitis Vaccines